ArticleJournal of applied clinical medical physics2026
A dosimetric study of photon energy and flattening filter mode combinations in Stereotactic Central Ablative Radiotherapy.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIn Stereotactic Central Ablative Radiotherapy (SCART), the volume of tumor receiving the full prescribed ablative dose decreases rapidly as the prescription dose increases, posing a critical challenge. To address this issue, this study investigates the dosimetric impact of combining various photon energies and flattening filter modes available on modern linear accelerators (linacs), aiming to provide more options for clinical application.
methodsFifty-one cases of abdominal large-volume tumors treated with conventional radiotherapy at the Second People's Hospital of Changzhou from January 2021 to August 2023 were retrospectively selected. Plans were created using the Monaco 5.11 treatment planning system. All plans employed volumetric modulated arc therapy (VMAT) with two coplanar 360° arcs (clockwise + counterclockwise). The two arcs used different combinations of photon energies/flattening filter modes: 6 MV & 6 MV, 6 MV & 10 MV, 6 MV & 6 MV flattening-filter-free (FFF), 10 MV & 10 MV, 6 MV-FFF & 6 MV-FFF, and 6 MV-FFF & 10 MV, while keeping all other planning parameters consistent.
resultsCompared to the standard 6 MV & 6 MV combination, the 6 MV & 10 MV combination reduced the dose to normal tissues without a statistically significant change in ablation volume. The 6 MV & 6 MV-FFF combination yielded significantly larger ablation volumes, albeit with a statistically significant increase in normal tissue dose, which remained within clinically acceptable limits. The 6 MV-FFF & 6 MV-FFF combination also yielded a significantly larger ablation volume, but the increase in normal tissue dose was not statistically significant. The 10 MV & 10 MV and 6 MV-FFF & 10 MV combinations reduced normal tissue dose while increasing ablation volume, though the increase was less than that achieved with the 6 MV & 6 MV-FFF and 6 MV-FFF & 6 MV-FFF combinations.
conclusionThe choice of energy/mode combination in SCART can be tailored to clinical priorities. For paramount organ-at-risk sparing, 6 MV & 10 MV is recommended. For maximizing ablation volume, 6 MV-FFF & 6 MV-FFF is recommended, followed by 6 MV & 6 MV-FFF. For a balanced approach, the 6 MV-FFF & 6 MV-FFF combination demonstrated the best overall performance, followed by the 6 MV-FFF & 10 MV combination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.